ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
5.90
-0.14 (-2.32%)
At close: Mar 6, 2026, 4:00 PM EST
5.84
-0.06 (-1.02%)
After-hours: Mar 6, 2026, 4:04 PM EST
ImageneBio Market Cap
ImageneBio has a market cap or net worth of $62.20 million as of March 6, 2026.
Market Cap
62.20M
Enterprise Value
-76.94M
1-Year Change
n/a
Ranking
Category
Stock Price
$5.90
Market Cap Chart
Since July 28, 2025, ImageneBio's market cap has decreased from $174.36M to $62.20M, a decrease of -64.32%. That is a compound annual growth rate of -81.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 62.20M | -15.36% |
| Dec 31, 2025 | 73.49M | -57.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InflaRx | 65.71M |
| Q32 Bio | 65.66M |
| TScan Therapeutics | 63.73M |
| Mereo BioPharma Group | 62.71M |
| eXoZymes | 61.43M |
| NeurAxis | 60.83M |
| Instil Bio | 60.16M |
| Spruce Biosciences | 59.80M |